Herjan JT Coelingh Bennink

Herjan JT Coelingh Bennink

MD, PhD – President

  • MD, Erasmus University Rotterdam, the Netherlands (1969).
  • PhD Thesis on Gestational Diabetes, University of Utrecht, the Netherlands (1980).
  • Residency Internal Medicine and Gynaecology/Obstetrics, University Hospital Leiden and University Hospital Utrecht, the Netherlands (1969-1976).
  • Fellowship Centre for Research in Reproductive Biology, University of Michigan, Ann Arbor, USA (1974).
  • Board Certification Gynaecology/Obstetrics, the Netherlands (1976).
  • Head of Obstetrical Department, thereafter Head of Reproductive Endocrinology, Department of Obstetrics/Gynecology, University Hospital Utrecht, the Netherlands (1976-1985).
  • Gynaecologist, Juliana Hospital Veenendaal, the Netherlands (1985-1987).
  • Global Executive VP of Clinical Development in Reproductive Medicine (RM), Organon, Oss, the Netherlands (1987-1997).
  • Global Executive VP RM: responsible for R&D and pipeline in RM, Organon, Oss, the Netherlands (1997-2000).
  • Professor Reproductive Medicine, Dutch speaking Free University Brussels (1997-2007).
  • Founder of Pantarhei Bioscience on December 28, 2000.
  • Founder of Pantarhei Oncology on September, 2014.
  • CEO and President at Pantarhei Bioscience and Pantarhei Oncology (2000-present).
  • Founder of Pandora Endocrine Innovation on 26 February 2019.
  • CEO and President at Pandora Endocrine Innovation (2019-present).